ICD-10 Coding for Ductal Carcinoma(C50.0, C50.911, C50.911B)
Comprehensive guide to ICD-10 coding for ductal carcinoma, including invasive and in situ types, with documentation requirements and coding tips.
Complete code families applicable to Ductal Carcinoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C50.911 | Malignant neoplasm of unspecified site of right female breast | Use when the specific site within the right breast is not documented. |
|
| D05.10 | Carcinoma in situ of unspecified breast | Use when DCIS is confirmed without specification of laterality. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutDuctal Carcinoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Ductal Carcinoma.
Failing to document receptor status
Impact
Clinical: Affects treatment decisions and prognosis., Regulatory: Non-compliance with documentation standards., Financial: Potential impact on reimbursement for targeted therapies.
Mitigation
Ensure receptor status is included in pathology reports., Review clinical notes for completeness before coding.
Using unspecified codes when specific site is documented
Impact
Reimbursement: May lead to reduced reimbursement due to lack of specificity., Compliance: Non-compliance with coding guidelines requiring specificity., Data Quality: Decreases accuracy of health records and data analytics.
Mitigation
Ensure documentation specifies the site and use the most specific code available.
Specificity of coding
Impact
Audits may target unspecified codes when documentation supports more specific coding.
Mitigation
Ensure all documentation is reviewed for specificity before coding.